Fisetin to Reduce Senescence and Mobility Impairment in PAD
Fisetin to Reduce Senescence and Mobility Impairment in PAD
Recruiting · NCT06399809 · Registry updated 2026-04-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fisetin to Reduce Senescence and Mobility Impairment in PAD | Ambulation Difficulty, Arterial Occlusive Diseases, Mobility Limitation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, intermittent vascular claudication, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Phase 2 | 2026-04-15 | NCT06399809 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Northwestern University | 381 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Northwestern University Feinberg School of Medicine | Chicago | United States | 1 |